Opko health, inc. (OPK)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Total revenues

901,935

990,266

966,006

1,117,494

491,738

91,125

96,530

47,044

27,979

28,494

4,418

License revenue

-

-

-

-

-

-

-

-

-

6,731

-

Costs and expenses:
Gross margin, excluding amortization of intangible assets

-

-

-

-

-

-

-

-

-

14,999

1,542

Selling, general and administrative

343,305

358,346

414,628

407,331

196,576

57,940

55,320

27,795

19,169

18,133

10,372

Research and development

117,870

125,586

126,435

113,871

99,488

83,571

53,902

19,520

11,352

5,949

10,836

In-process research and development

-

-

-

-

-

12,055

0

0

-

-

-

Contingent consideration

-14,854

-16,816

-3,423

16,954

5,050

24,446

6,947

785

0

-

-

Amortization of Intangible Assets

64,800

67,900

71,500

64,400

27,977

10,919

11,133

8,335

3,404

2,053

481

Asset impairment charges

92,400

21,778

13,194

0

-

-

-

-

-

-

-

Grant repayment

-

-

-

-

25,889

0

0

-

-

-

-

Write-off of acquired in-process research and development

-

-

-

-

-

-

-

-

-

-

2,000

Total costs and expenses

1,175,987

1,161,463

1,242,448

1,214,045

590,219

236,940

176,162

84,313

51,168

26,135

23,689

Operating Income (Loss)

-274,052

-171,197

-276,442

-96,551

-98,481

-145,815

-79,632

-37,269

-23,189

-11,136

-22,147

Other income and (expense), net:
Interest income

1,710

1,240

610

478

255

771

376

188

288

24

24

Interest expense

21,516

11,890

6,601

7,430

8,419

12,263

13,802

1,405

1,005

1,215

1,760

Fair value changes of derivative instruments, net

174

3,043

52

2,778

-39,083

-10,632

-45,942

1,218

-39

-

-

Other income (expense), net

-11,281

1,535

10,457

3,903

7,730

-3,088

34,782

164

-288

-844

-1,916

Other income and (expense), net

-30,913

-6,072

4,518

-271

-39,517

-25,212

-24,586

165

-1,044

347

180

Loss before income taxes and investment losses

-304,965

-177,269

-271,924

-96,822

-137,998

-171,027

-104,218

-37,104

-24,233

-11,980

-24,063

Income tax provision

7,060

-38,726

18,855

-56,115

-113,675

24

1,672

-9,626

-19,358

-18

-25

Net loss before investment losses

-312,025

-138,543

-290,779

-40,707

-24,323

-171,051

-105,890

-27,478

-4,875

-

-

Loss from investments in investees

-2,900

-14,497

-14,471

-7,652

-7,105

-3,587

-11,456

-2,062

-1,589

-714

-353

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-12,676

-24,391

Income from discontinued operations, net of tax

-

-

-

-

-

-

-

-

5,181

-6,250

-5,722

Loss before investment losses

-

-

-

-

-

-

-

-

-

-11,962

-24,038

Net loss

-

-

-

-48,359

-31,428

-174,638

-117,346

-29,540

-1,283

-18,926

-

Loss per share, basic and diluted:
Net loss

-

-

-

-

-

-

-

-

-6,464

-

-

Less: Net loss attributable to noncontrolling interests

-

-

-

-

-1,400

-2,972

-2,939

-492

0

-

-

Net loss

-314,925

-153,040

-305,250

-

-

-

-114,407

-29,048

-1,283

-18,926

-30,113

Preferred stock dividend

-

-

-

-

-

-

420

2,240

2,379

2,624

4,718

Net loss attributable to common shareholders

-

-

-

-

-30,028

-171,666

-114,827

-31,288

-3,662

-21,550

-34,831

Loss per share basic and diluted:
Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-0.12

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-0.03

Loss per share (in dollars per share)

-0.53

-0.27

-0.55

-0.09

-0.06

-0.41

-0.32

-0.11

-0.01

-0.08

-0.15

Loss from continuing operations, per basic and diluted share

-

-

-

-

-

-

-

-

-0.03

-0.06

-

Income from discontinued operations, per basic and diluted share

-

-

-

-

-

-

-

-

0.02

-0.02

-

Weighted average common shares outstanding, basic and diluted (in shares)

595,454

563,143

559,160

-

488,065

422,014

355,095

295,750

280,673

255,095

-

Earnings Per Share, Diluted

-

-

-

-0.10

-

-

-

-

-

-

-

Weighted average common shares outstanding, basic (in shares)

-

-

-

550,847

-

-

-

-

-

-

-

Weighted average common shares outstanding, diluted (in shares)

-

-

-

555,605

-

-

-

-

-

-

233,191

Services
Total revenues

716,434

813,248

782,710

928,572

329,739

8,666

11,658

1,749

135

-

-

Cost of service revenue

511,206

546,654

558,953

564,103

193,305

9,372

10,419

27,878

17,243

13,495

2,876

Products
Total revenues

112,184

107,112

107,759

83,467

80,146

76,983

68,161

45,295

27,844

21,763

4,418

Cost of service revenue

61,278

57,982

61,177

47,379

41,934

38,637

38,441

-

-

-

-

Transfer Of Intellectual Property And Other [Member]
Total revenues

73,317

69,906

75,537

105,455

81,853

5,476

16,711

0

0

-

-